Sirolimus- vs. paclitaxel-eluting stent to coronary intervention in dialysis patients

Daisuke Kamoi1, Hideki Ishii, Hiroshi Takahashi

  • 1Department of Cardiology, Nagoya Kyoritsu Hospital, Nagoya, Japan.

Insights

Sirolimus-eluting stents (SES) and paclitaxel-eluting stents (PES) showed similar restenosis rates in hemodialysis patients undergoing percutaneous coronary intervention. Patients on hemodialysis remain at high risk for restenosis despite drug-eluting stent treatment.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Nephrology

Background:

  • Patients on maintenance hemodialysis (HD) face elevated restenosis risk post-percutaneous coronary intervention (PCI).
  • Drug-eluting stents (DES) are used to mitigate this risk, but comparative data in HD patients is limited.

Purpose of the Study:

  • To compare the efficacy of sirolimus-eluting stents (SES) versus paclitaxel-eluting stents (PES) in preventing restenosis.
  • To evaluate angiographic outcomes in hemodialysis patients with coronary artery disease treated with SES or PES.

Main Methods:

  • 100 maintenance hemodialysis patients undergoing PCI were randomized to SES or PES.
  • Follow-up angiographic outcomes were assessed at 8 months.

Main Results:

  • No significant difference in angiographical restenosis rates between SES (19.7%) and PES (20.0%) groups (p=0.97).
  • Similar late loss and no significant differences in major adverse cardiac events or target lesion revascularization between groups.

Conclusions:

  • Both SES and PES demonstrate comparable angiographic outcomes in hemodialysis patients at 8-month follow-up.
  • Hemodialysis patients remain at high risk for restenosis, even after treatment with current DES.
Abstract

Related Concept Videos

Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis01:30

Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis

Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in critically...
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this measurement...